Skip to main navigation Analyst Coverage Exagen is covered by the following analysts Firm Analyst BTIG Mark Massaro Canaccord Genuity Kyle Mikson Cantor Fitzgerald Charles C. Duncan, PhD Cowen and Company Max Masucci KeyBanc Paul Knight William Blair Brian Weinstein Exagen is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Exagen's performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Exagen or its management. Exagen does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations. Print Page Email Alerts RSS Feeds Investor Contacts © 2021 Exagen Inc. | All Rights Reserved SA1168 Footer

Skip to main navigation Events Upcoming Events Nov 18, 2021 at 10:30 AM EST Exagen at the 2021 Canaccord Genuity Virtual MedTech, Diagnostics and Digital Health and Services Forum Click here for Webcast Past Events Nov 10, 2021 at 4:30 PM EST Exagen Third Quarter 2021 Financial Results Conference Call Click here for Webcast Sep 27, 2021 at 2:40 PM EDT Exagen Inc. Fireside Chat at the Cantor Fitzgerald Virtual Global Healthcare Conference Click here for Webcast Aug 12, 2021 at 12:00 PM EDT Exagen Inc. Fireside Chat at Canaccord Genuity 41st Annual Growth Conference Click here for Webcast Aug 9, 2021 at 4:30 PM EDT Exagen Second Quarter 2021 Financial Results Conference Call Click here for Webcast Jun 2, 2021 at 11:20 AM EDT Exagen at the William Blair 41st Annual Growth Stock Conference Click here for Webcast May 11, 2021 at 4:30 PM EDT Exagen First Quarter 2021 Financial Results Conference Call Click here for Webcast Mar 16, 2021 at 4:30 PM EDT Exagen Fourth Quarter 2020 Financial Results Conference Call Click here for Webcast Jan 14, 2021 at 11:30 AM EST Exagen at the 2021 ICR Conference Dec 1 - Dec 3, 2020 Exagen at the Evercore ISI 3rd Annual HealthCONx Conference Nov 30 - Dec 3, 2020 Exagen at the Piper Sandler 32nd Annual Virtual Healthcare Conference Click here for Webcast Pagination Current page 1 Page 2 Page 3 Next page next › Last page last » Print Page Email Alerts RSS Feeds Investor Contacts © 2021 Exagen Inc. | All Rights Reserved SA1168 Footer

Research & Development At Exagen, our mission is to continue translating our discovery & development into real solutions that are safe, reliable and cost effective. Our research & development team created our current AVISE product line that encompasses seven game-changing products and they aren’t stopping there. They continue to strive for scientific excellence through collaborations, ongoing education, research and testing both independently and with some of the best commercial and medical professionals in the world. To learn more about Exagen’s Research & Development initiatives and what we are doing to help deliver next-generation physician solutions, please contact us at info@exagen.com. ©2021 Exagen Inc. | All Rights Reserved SA1168